Endo International and Allergan could avoid going to trial in a landmark case out of Ohio accusing pharmaceutical companies of marketing practices that preceded the opioid epidemic.

source https://finance.yahoo.com/m/216078e0-6519-35e7-adff-b322dd910482/opioid-epidemic%3A-will-pharmas.html?.tsrc=rss